For the quarter ending 2026-03-31, KALA had -$5,793K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -1,621 | 686 | -7,564 | -20,102 |
| Depreciation and amortization | - | 54 | 128 | 135 |
| Non-cash operating lease cost | - | 0 | 96 | 184 |
| Impairment of right-of-use assets | - | 0 | 1,411 | - |
| Lease liabilities and other long-term liabilities | - | -1,533 | -100 | -180 |
| Gain on extinguishment of debt | - | 5,793 | - | - |
| (gain) loss on fair value remeasurement of contingent consideration | - | 0 | 4,833 | -174 |
| Amortization of debt discount and other non-cash interest | - | -1,142 | 116 | 359 |
| Stock-based compensation | -471 | 401 | 2,044 | 4,550 |
| Issuance of common stock for service contract | 1,755 | 1,553 | - | - |
| Issuance of common stock for settlement agreements | - | 524 | - | - |
| Loss on sale or disposal of property and equipment | - | -549 | - | - |
| Prepaid expenses and other current assets | 1,621 | -1,245 | 1,457 | 105 |
| Other long-term assets | - | -151 | - | 7 |
| Accounts payable | 58 | 69 | 259 | 30 |
| Accrued expenses and other current liabilities | -995 | -1,313 | -984 | -1,596 |
| Net cash used in operating activities | -2,895 | -4,556 | -10,877 | -16,558 |
| Purchases of property and equipment and other assets | - | 0 | -1 | 16 |
| Payment for short-term investment | 7,000 | - | - | - |
| Net cash used in investing activities | -7,000 | 0 | 1 | -16 |
| Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | - | 0 | 60 | 13 |
| Proceeds from common stock offerings, net of offering costs of 866 | - | 9,134 | - | - |
| Payment of principal on finance lease | - | 4 | 30 | 58 |
| Payment of principal and payment fee on debt | - | 19,913 | 0 | 2,500 |
| Payment of issuance costs from issuance of common stock and series i preferred stock | - | 0 | 0 | 120 |
| Proceeds from issuance of series aaa preferred stock, net of issuance cost | 4,102 | 1,800 | - | - |
| Net cash provided by (used in) financing activities | 4,102 | -8,983 | 30 | -2,665 |
| Net (decrease) increase in cash and cash equivalents | -5,793 | -13,539 | -10,846 | -19,239 |
| Cash and cash equivalents at beginning of period | 7,557 | 21,096 | 51,181 | - |
| Cash and cash equivalents at end of period | 1,764 | 7,557 | 21,096 | - |
KALA BIO, Inc. (KALA)
KALA BIO, Inc. (KALA)